🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

8,395 results for “La” Clear

  1. AMPICILLIN , AMOXICILLIN AND BETA-LACTAMASE INHIBITOR , OFLOXACIN , MOXIFLOXACIN , AZITHROMYCIN , LEVOFLOXACIN , AMOXICILLIN , PRISTINAMYCIN , ERYTHROMYCIN , CIPROFLOXACIN , CLARITHROMYCIN

    Pari Pharma GmbH

    Community acquired pneumonia (CAP)

    approved small molecule active

    1 trial

  2. ARALAST Alpha1-Proteinase Inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved small molecule terminated

    1 trial

  3. ARALAST NP

    Takeda

    Chronic Obstructive Pulmonary Disease

    approved mab terminated

    1 trial

  4. ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets

    The George Institute

    Risk of stroke by Atrial Fibrillation

    approved small molecule active

    1 trial

  5. ATORVASTATIN, PLACEBO

    Disc Medicine

    Atherosclerosis

    approved small molecule active

    1 trial

  6. Abemaciclib

    Eli Lilly and Company

    Breast Neoplasms

    approved small molecule completed

    1 trial

  7. Ablation

    Rhythm Pharmaceuticals Netherlands B.V.

    Atrial Fibrillation

    approved other terminated

    1 trial

  8. Access Arm

    Rhythm Pharmaceuticals Netherlands B.V.

    Heart Failure

    approved other completed

    1 trial

  9. Acetazolamide

    United Therapeutics Europe Ltd

    Hypobaric Hypoxia

    approved small molecule active

    1 trial

  10. Advair HFA 230mcg/21mcg, Dupixent 300 mg solution for injection in pre-filled syringe, Placebo matching to dupilumab, Advair HFA 115 mcg/21 mcg

    Lacuna Pharma Pty Ltd

    Asthma

    approved small molecule active

    1 trial

  11. Aflibercept

    Regeneron UK Limited

    Exudative Macular Degeneration

    approved small molecule completed

    1 trial

  12. Aflibercept

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule active

    1 trial

  13. Aflibercept

    Regeneron UK Limited

    Submacular Vascularized Pigment Epithelial Detachments

    approved small molecule completed

    1 trial

  14. Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    2 trials

  15. Aflibercept

    Regeneron UK Limited

    Fibrovascular Pigment Epithelial Detachment

    approved small molecule terminated

    1 trial

  16. Aflibercept (2.0 mg)

    Regeneron UK Limited

    Macular Edema With Central Retinal Vein Occlusions

    approved small molecule completed

    1 trial

  17. Aflibercept (BAY86-5321, Eylea)

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  18. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Neovascular Macular Degeneration

    approved small molecule completed

    1 trial

  19. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  20. Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    approved small molecule active

    1 trial

  21. Aflibercept Ophthalmic

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  22. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial

  23. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  24. Ambulatory Oxygen

    United Therapeutics Europe Ltd

    Lung; Disease, Fibroid (Chronic)

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources